ARCHIVES

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

NIH oncology peer reviewers are protesting the outcome of a recent meeting in which their own grant applications fared so poorly that the reviewers said they were penalized for their service.

May 6, 2005

In Brief: Pollock Named Director of Surgical Oncology At Ohio State Comprehensive Cancer Center

May 8, 2013

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

May 23, 1986

NIAID Advisors Ok Recompetition of Pediatric ACTGs

February 14, 1992

ACS Awards Medals to Holland, Sporn, RWJ Foundation

December 2, 1994

NIH Director Collins Publishes Third Book About Faith In God

March 5, 2010